Chargement en cours...
Pathway inhibition: emerging molecular targets for treating glioblastoma
Insights into the molecular pathogenesis of glioblastoma have not yet resulted in relevant clinical improvement. With standard therapy, which consists of surgical resection with concomitant temozolomide in addition to radiotherapy followed by adjuvant temozolomide, the median duration of survival is...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3107100/ https://ncbi.nlm.nih.gov/pubmed/21636705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nor039 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|